Biao Xi ACEA Biosciences, Inc Biography Publications Institution JoVE Articles Biao Xi has not added a biography. If you are Biao Xi and would like to personalize this page please email our Author Liaison for assistance. Publications AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients Molecular Cancer Therapeutics. 11, 2016 | Pubmed ID: 27573423 Multi-parametric Assessment of Cardiomyocyte Excitation-contraction Coupling Using Impedance and Field Potential Recording: A Tool for Cardiac Safety Assessment Journal of Pharmacological and Toxicological Methods. Sep-Oct, 2016 | Pubmed ID: 27282640 Dynamic Monitoring of Beating Periodicity of Stem Cell-derived Cardiomyocytes As a Predictive Tool for Preclinical Safety Assessment British Journal of Pharmacology. Mar, 2012 | Pubmed ID: 21838757 Functional Cardiotoxicity Profiling and Screening Using the XCELLigence RTCA Cardio System Journal of Laboratory Automation. Dec, 2011 | Pubmed ID: 22093298 Rapid and Quantitative Assessment of Cell Quality, Identity, and Functionality for Cell-based Assays Using Real-time Cellular Analysis Journal of Biomolecular Screening. Mar, 2011 | Pubmed ID: 21310850 Natural Product Derivative Bis(4-fluorobenzyl)trisulfide Inhibits Tumor Growth by Modification of Beta-tubulin at Cys 12 and Suppression of Microtubule Dynamics Molecular Cancer Therapeutics. Dec, 2009 | Pubmed ID: 19996274 Dynamic and Label-free Cell-based Assays Using the Real-time Cell Electronic Sensing System Assay and Drug Development Technologies. Oct, 2006 | Pubmed ID: 17115930 Live Cell Quality Control and Utility of Real-time Cell Electronic Sensing for Assay Development Assay and Drug Development Technologies. Oct, 2006 | Pubmed ID: 17115925 Un esempio di potenza in tempo reale per le cellule T del recettore dell'antigene chimerico rivolte alle cellule tumorali solide ed ematologiche Biao Xi1, Robert Berahovich2, Hua Zhou2, Shirley Xu2, Yuehua Wei2, Jasper Guan2, Hizkia Harto2, Jian Guan2, Lijun Wu2, David Santa Ana1,3, Fabio Cerignoil1, Brandon Lamarche1, Yama A. Abassi1, Vita Golubovskaya2 1ACEA Biosciences, Inc, 2ProMab Biotechnologies. Inc, 3ACEA Therapeutics JoVE 59033 Immunology and Infection
Un esempio di potenza in tempo reale per le cellule T del recettore dell'antigene chimerico rivolte alle cellule tumorali solide ed ematologiche Biao Xi1, Robert Berahovich2, Hua Zhou2, Shirley Xu2, Yuehua Wei2, Jasper Guan2, Hizkia Harto2, Jian Guan2, Lijun Wu2, David Santa Ana1,3, Fabio Cerignoil1, Brandon Lamarche1, Yama A. Abassi1, Vita Golubovskaya2 1ACEA Biosciences, Inc, 2ProMab Biotechnologies. Inc, 3ACEA Therapeutics JoVE 59033 Immunology and Infection